Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

P450-Based Drug-Drug Interactions of Amiodarone and its Metabolites: Diversity of Inhibitory Mechanisms

Matthew G. McDonald, Nicholas T. Au and Allan E. Rettie
Drug Metabolism and Disposition November 2015, 43 (11) 1661-1669; DOI: https://doi.org/10.1124/dmd.115.065623
Matthew G. McDonald
Department of Medicinal Chemistry, University of Washington, Seattle, Washington (M.G.M., N.T.A., A.E.R.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas T. Au
Department of Medicinal Chemistry, University of Washington, Seattle, Washington (M.G.M., N.T.A., A.E.R.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allan E. Rettie
Department of Medicinal Chemistry, University of Washington, Seattle, Washington (M.G.M., N.T.A., A.E.R.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 43 no. 11 1661-1669
DOI 
https://doi.org/10.1124/dmd.115.065623
PubMed 
26296708

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received May 21, 2015
  • Accepted August 20, 2015
  • Published online September 29, 2015.

Article Versions

  • Earlier version (August 21, 2015 - 06:23).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Matthew G. McDonald,
  2. Nicholas T. Au, and
  3. Allan E. Rettie
  1. Department of Medicinal Chemistry, University of Washington, Seattle, Washington (M.G.M., N.T.A., A.E.R.)
  1. Address correspondence to:
    Allan E. Rettie, Department of Medicinal Chemistry, University of Washington, Box 357610, Seattle, WA, 98195. E-mail: rettie{at}u.washington.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 201714118
Sep 20170316
Oct 201724617
Nov 201735222
Dec 201703912
Jan 201815115
Feb 201873220
Mar 201873017
Apr 201814710
May 201813711
Jun 201842813
Jul 20182298
Aug 201813424
Sep 201811814
Oct 201803518
Nov 201801913
Dec 20185268
Jan 20194519
Feb 201976311
Mar 201923710
Apr 201922432
May 201912016
Jun 201922913
Jul 201952310
Aug 201923118
Oct 201915213
Nov 201974124
Dec 2019102812
Jan 202013612
Feb 202033211
Mar 202023929
May 202013521
Jun 202055318
Jul 20202289
Aug 202024516
Sep 202033814
Oct 202014719
Nov 202035329
Dec 202096426
Jan 2021513518
Feb 202185217
Mar 202144017
Apr 202144720
May 202153914
Jun 202136713
Jul 202116319
Aug 202165214
Sep 202168233
Oct 20216965
Nov 20217294
Dec 20215122
Jan 20223765
Feb 20223563
Mar 20223721
Apr 20221973
May 20225043
Jun 20224432
Jul 202227212
Aug 20226264
Sep 20226532
Oct 20224671
Nov 20225976
Dec 20224835
Jan 20235563
Feb 20233839
Mar 20234075

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 43 (11)
Drug Metabolism and Disposition
Vol. 43, Issue 11
1 Nov 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
P450-Based Drug-Drug Interactions of Amiodarone and its Metabolites: Diversity of Inhibitory Mechanisms
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Inhibitory Metabolites in Amiodarone Drug-Drug Interactions

Matthew G. McDonald, Nicholas T. Au and Allan E. Rettie
Drug Metabolism and Disposition November 1, 2015, 43 (11) 1661-1669; DOI: https://doi.org/10.1124/dmd.115.065623

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Inhibitory Metabolites in Amiodarone Drug-Drug Interactions

Matthew G. McDonald, Nicholas T. Au and Allan E. Rettie
Drug Metabolism and Disposition November 1, 2015, 43 (11) 1661-1669; DOI: https://doi.org/10.1124/dmd.115.065623
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • AKRs and GUSs in Testosterone Disposition
  • Olanzapine Glucuronidation in Humanized Mice
  • rs2242480 Regulates the Expression of CYP3A4 and CYP3A5
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics